Kineret, Anakinra News

July 8, 2009. Biovitrum AB has entered an exclusive distribution and marketing agreement with Megapharm Ltd.

Speaking to the American Medical Association last month, President Obama waxed enthusiastic about countries that "spend less" than the U.S. on health care.

Copenhagen, Denmark, Friday 12 June 2009: First line treatment with anakinra receptor antagonist), results in a 'good' clinical response in patients newly diagnosed with systemic onset juvenile idiopathic arthritis , and restores the deficient IL-18 response of natural killer cells*, according to a new study presented today at PReS 2009, a joint ...

U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH NIH News National Institute of Arthritis and Musculoskeletal and Skin Diseases Embargoed for Release: Wednesday, June 3, 2009, 5:00 p.m. EDT CONTACT: Trish Reynolds, 301-496-8190, SCIENTISTS DISCOVER NEW GENETIC IMMUNE DISORDER IN CHILDREN Your immune system plays an ...

In autoinflammatory diseases, however, the immune system goes awry, causing unprovoked and dangerous inflammation.

Mutations in the interleukin-1 receptor antagonist gene are associated with an autoinflammatory disease involving skin and bone, and symptoms can be resolved by recombinant IL1RN , according to two studies in the June 4 issue of the New England Journal of Medicine .

Your immune system plays an important function in your health-it protects you against viruses, bacteria, and other toxins that can cause disease.

May 1, 2009 -- Biologic therapies often prescribed for rheumatoid arthritis do help improve symptoms but don't eliminate them, according to a new study.

A single intraarticular injection of the interleukin-1 receptor antagonist anakinra for treatment of knee osteoarthritis has no effect on knee pain, function, stiffness, or cartilage turnover, results of a clinical trial indicate.

There has been evidence from some studies that patients treated with antiTNF- agents are at an increased risk of bacterial infections, but little is known about the risk of viral infections, such as herpes ...

Main Category: Arthritis / Rheumatology Also Included In: Immune System / Vaccines ; Biology / Biochemistry Article Date: 23 Feb 2009 - 2:00 PST printer friendly view / write opinions A strain of laboratory ...

Anti-tumor necrosis factor alpha drugs are the newest class of medications being used to treat Crohn's disease and ulcerative colitis.

Use of certain medications for the treatment of rheumatoid arthritis appears to be associated with an increased risk for shingles, German researchers said.

Feb. 17, 2009 -- Some of the powerful new drugs that offer relief to rheumatoid arthritis sufferers may increase risk of a different kind of suffering: shingles .

Context The risk of bacterial infection is increased in patients treated with drugs that inhibit tumor necrosis factor .

Feb 16, 2009 - Research and Markets has announced the addition of the " Competitor Analysis: Interleukin-1 and Receptor Antagonists " report to their offering.

Newer ae 'econd-line?drugs to control rheumatoid arthritis include leflunomide, and the ae iologic?medications etanercept, infliximab, anakinra, and adalimumab.

Washington, Jan 21 : Anakinra may be good for rheumatoid arthritis but a study warns that it also carries potential risks.

Placing vulnerable children with relatives is a viable option, a new study by Cochrane Researchers suggests.

Trainee surgeons who add virtual reality training to standard 'apprenticeship' training in key-hole surgery learn more quickly, work with greater accuracy and have less errors than those with no VR training, ...